Chairman, New Cardiovascular Horizons Business of Peripheral Interventions
Co-Chairman, New Cardiovascular Horizons Annual Conference
After a successful career as a Wall Street medical device analyst, Mary Yost co-founded THE SAGE GROUP to specialize in what was at the time a little known, but widely prevalent cardiovascular problem, peripheral artery disease (PAD). Over the past decade THE SAGE GROUP has become a leader in PAD research and consulting.
Ms. Yost’s training as an economist at the University of California Berkeley has led to extensive research on the economic and societal costs of PAD and critical limb ischemic (CLI) as well as on the costs and consequences of dysvascular amputation.
Other areas of focus include the epidemiology of PAD and CLI, ischemic diabetic foot ulcers (DFU) and acute limb ischemia.
Ms. Yost developed the Diabetes Method, a population-based projection model to estimate the number of people with PAD, CLI, intermittent claudication (IC) and asymptomatic disease. To date the Diabetes Method has been employed to estimate PAD in the US, Western Europe, India, Mexico and South America.
Currently a member of the Horizons International Peripheral Group (HIPG) and Save A Leg Save A Life (SALSAL), Ms. Yost previously served on the Board of the Vascular Disease Foundation.
New Cardiovascular Horizons 3639 Ambassador Caffery Pkwy. Suite 605 Lafayette, LA 70503 Ph: 337.993.7920 Fax: 337.993.7922 Email: email@example.com
Get the latest updates to the Agenda, Faculty, Exhibitors/Sponsors, Daily News, Abstracts and more by downloading the mobile clicking html5 logo to access it through your browser